Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
Realbio Genomics Institute, Shanghai 200123, China.
Nutrients. 2022 Aug 28;14(17):3546. doi: 10.3390/nu14173546.
Recent research advances examining the gut microbiome and its association with human health have indicated that microbiota-targeted intervention is a promising means for health modulation. In this study, elderly people in long-term care (aged 83.2 ± 5.3 year) with malnutrition (MNA-SF score ≤ 7) were recruited in a community hospital for a 12-week randomized, single-blind clinical trial with Clostridium butyricum. Compared with the basal fluctuations of the control group, an altered gut microbiome was observed in the intervention group, with increased (p < 0.05) Coprobacillus species, Carnobacterium divergens, and Corynebacterium_massiliense, and the promoted growth of the beneficial organisms Akketmanse muciniphila and Alistipes putredinis. A concentrated profile of 14 increased Kyoto Encyclopedia of Genes and Genomes (KEGG) orthologs (KOs) that were enriched in cofactor/vitamin production and carbohydrate metabolism pathways were discovered; the genes were found to be correlated (p < 0.05) with an elevated abundance of plasma metabolites and short-chain fatty acids (SCFAs), unsaturated medium- to long-chain fatty acids (MFA, LFA), carnitines, and amino acids, thus suggesting a coordinated ameliorated metabolism. Proinflammatory factor interferon-gamma (IFN-γ) levels decreased (p < 0.05) throughout the intervention, while the gut barrier tight junction protein, occludin, rose in abundance (p = 0.059), and the sensitive nutrition biomarker prealbumin improved, in contrast to the opposite changes in control. Based on our results obtained during a relatively short intervention time, C. butyricum might have great potential for improving nutrition and immunity in elderly people in long-term care with malnutrition through the alteration of gut microbiota, increasing the abundance of beneficial bacteria and activating the metabolism in SCFA and cofactor/vitamin production, bile acid metabolism, along with efficient energy generation.
近期有关肠道微生物组及其与人类健康关联的研究进展表明,靶向微生物组的干预措施是一种很有前途的健康调节手段。在这项研究中,我们招募了社区医院长期护理(83.2±5.3 岁)的营养不良老年人(MNA-SF 评分≤7),进行为期 12 周的随机、单盲临床试验,用丁酸梭菌进行干预。与对照组的基础波动相比,干预组的肠道微生物组发生了改变,其中 Coprobacillus 种、Carnobacterium divergens 和 Corynebacterium_massiliense 增多(p<0.05),有益菌 Akkermansia muciniphila 和 Alistipes putredinis 的生长也得到了促进。我们发现了一个集中的 14 个 Kyoto Encyclopedia of Genes and Genomes(KEGG)直系同源物(KO)图谱,这些 KO 富集在辅酶/维生素产生和碳水化合物代谢途径中;这些基因与血浆代谢物和短链脂肪酸(SCFA)、不饱和中长链脂肪酸(MFA、LFA)、肉碱和氨基酸的丰度升高相关(p<0.05),提示代谢协同改善。促炎因子干扰素-γ(IFN-γ)水平在整个干预过程中降低(p<0.05),而肠道屏障紧密连接蛋白 occludin 的丰度增加(p=0.059),敏感的营养生物标志物前白蛋白也得到改善,而对照组则发生相反的变化。基于我们在相对较短的干预时间内获得的结果,丁酸梭菌可能通过改变肠道微生物组,增加有益菌的丰度,激活 SCFA 和辅酶/维生素产生、胆汁酸代谢以及有效的能量生成代谢,从而改善长期护理中营养不良老年人的营养和免疫功能。